Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2024 -- Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows.The two drugs are metformin, one of the most widely used diabetes medications, and the.
Science Daily: Pharmacology News
NOVEMBER 18, 2024
An international team of researchers has achieved an unprecedented milestone: the creation of mouse stem cells capable of generating a fully developed mouse using genetic tools from a unicellular organism, with which we share a common ancestor that predates animals. This breakthrough reshapes our understanding of the genetic origins of stem cells, offering a new perspective on the evolutionary ties between animals and their ancient single-celled relatives.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2024 -- People on blood thinners have a doubled risk of dangerous internal bleeding if they also take a non-steroidal anti-inflammatory drug (NSAID) like ibuprofen or naproxen, a new study warns.People typically are prescribed.
Science Daily: Pharmacology News
NOVEMBER 18, 2024
A theoretical astrophysicist may have solved a nearly two-decade-old mystery over the origins of an unusual 'zebra' pattern seen in high-frequency radio pulses from the Crab Nebula.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2024 -- One in five cases of dengue fever can be linked to climate change, and future surges in the mosquito-borne virus are inevitable, a new study says.About 19% of current dengue cases can be tied to climate change, which has.
Science Daily: Pharmacology News
NOVEMBER 18, 2024
An international group of authors who developed the science behind net zero demonstrate that relying on 'natural carbon sinks' like forests and oceans to offset ongoing CO2 emissions from fossil fuel use will not actually stop global warming. The science of net zero, developed over 15 years ago, does not include these natural carbon sinks in the definition of net human-induced CO2 emissions.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
NOVEMBER 18, 2024
Humans and animals move with remarkable economy without consciously thinking about it by utilizing the natural oscillation patterns of their bodies. A new tool can now utilize this knowledge for the first time to make robots move more efficiently.
Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2024 -- An E. coli outbreak linked to organic carrots has sickened 39 people in 18 states, U.S. health officials reported Sunday.Supplied by California-based Grimmway Farms and sold under popular brand names such as Nature’s P.
Science Daily: Pharmacology News
NOVEMBER 18, 2024
A newly discovered pterosaur fossil is shedding light on the evolutionary journey of these ancient flying reptiles. This complete specimen, named Skiphosoura bavarica, provides crucial insights into how pterosaurs transitioned from early, smaller forms to the later, gigantic species. By analysing the unique features of Skiphosoura, paleontologists can now trace the step-by-step evolution of pterosaurs, including changes in head size, neck length, wing structure, and tail length.
Nvidia Developer: Drug Discovery
NOVEMBER 18, 2024
AI models for science are often trained to make predictions about the workings of nature, such as predicting the structure of a biomolecule or the properties of. AI models for science are often trained to make predictions about the workings of nature, such as predicting the structure of a biomolecule or the properties of a new solid that can become the next battery material.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
NOVEMBER 18, 2024
It turns out gaming is good for you! New research indicates massive multiplayer online gamers learn by gaming and their skills in the workplace are enriched by those seemingly endless hours previously thought of as frittering away time.
Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2924 -- A dose of green may be just what school kids with anxiety, depression and other mental health issues need, new research shows.Canadian investigators found that a school program that let 10- to 12-year-olds spend a little.
Science Daily: Pharmacology News
NOVEMBER 18, 2024
Researchers have discovered a mechanism behind the yo-yo effect: fat cells have a memory that is based on epigenetics.
Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2024 -- Angry outbursts are common among children, as siblings squabble and kids protest the unfairness of rules like screen time limits.Now, a new survey shows that many parents struggle to manage their kids’ anger, and some even s.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
BioPharma Drive: Drug Pricing
NOVEMBER 18, 2024
The agency's openness to a targeted pivotal study shows it’s still willing to consider accelerated clearance for Duchenne gene therapies despite questions about their effectiveness.
Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2024 -- It's long been known that certain structural qualities of the human heart -- its size, chamber volume -- can influence cardiovascular health.British scientists say they're now discovering that the gene-directed shape of a.
Science Daily: Pharmacology News
NOVEMBER 18, 2024
The history of a major animal group, composed of millions of species of insects, arachnids, and nemotodes, has been elusive -- until now. A team has now identified the oldest known ecdysozoan in the fossil record and the only one from the Precambrian period.
Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2024 -- It’s possible to correct a woman’s pelvic prolapse using her own muscle tissue in robot-assisted surgery, a new study demonstrates.In the procedure, tendon muscle is transferred from the thigh to the uterus or cervix, rep.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
LifeSciVC
NOVEMBER 18, 2024
“May you live in interesting times” – or so goes the phrase. In 1966, RFK Jr’s father famously used that quote to capture the turbulence of the times, and continued: “Like it or not, we live in interesting times. They are times of danger and uncertainty, but they are also the most creative of any time in the history of mankind.” Ironically, this is how biotech feels right now in November 2024, dealing with the shockwaves of Trump’s nomination of RFK Jr as the nation’s new health czar.
Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2024 -- Folks who stress-eat fatty foods like cookies, chips and ice cream might be able to protect their health with a nice cup of cocoa or green tea, a new study says.Drinking cocoa that’s high in healthy flavanols along with a f.
Drug Patent Watch
NOVEMBER 18, 2024
The concept of a blockbuster drug, defined as a medication generating at least $1 billion in annual sales, has long been a cornerstone of the pharmaceutical industry. However, the question arises whether a drug can achieve blockbuster status without heavily relying on U.S. sales.
Drugs.com
NOVEMBER 18, 2024
MONDAY, Nov. 18, 2024 -- As Africa continues to battle an outbreak of the newer "clade Ib" strain of mpox, California officials have confirmed the first known U.S. case of this strain of the virus.The subtype of clade I mpox virus has already.
BioPharma Drive: Drug Pricing
NOVEMBER 18, 2024
Explore solutions to reduce variability in gene expression during cell line development.
Science Daily: Pharmacology News
NOVEMBER 18, 2024
Through the intricate study of lava tubes -- caves formed following volcanic eruptions when lava cools down -- an international team of researchers has uncovered clues about Earth's ancient environments that could be significant in the search for life on Mars.
BioPharma Drive: Drug Pricing
NOVEMBER 18, 2024
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain pediatric patients with an aggressive form of acute leukemia.
Drug Patent Watch
NOVEMBER 18, 2024
The pharmaceutical industry is undergoing a significant shift, with emerging markets offering the next growth opportunity. This growth is driven by several factors, including the increasing prevalence of chronic diseases, cost-effectiveness, and patent expirations of branded drugs.
BioPharma Drive: Drug Pricing
NOVEMBER 18, 2024
Phase 1 data indicate Intellia’s medicine could be a powerful treatment for a cardiac form of ATTR amyloidosis. But rival drugs are further ahead.
Covalent Modifiers
NOVEMBER 18, 2024
Conghao Gai, Hairong Zeng , Haoming Xu, Xiaoyun Chai, Yan Zou, Chunlin Zhuang, Guangbo Ge, Qingjie Zhao European Journal of Medicinal Chemistry, 2024 [link] Isocitrate dehydrogenase (IDH) is an enzyme that catalyses the oxidative decarboxylation of isocitrate, producing α-ketoglutarate (α-KG) relative to the hydroxylation of substrates. However, IDH mutants can further reduce α-KG to 2-hydroxyglutarate (2-HG) which competitively inhibits α-KG dependent enzymes, leading to the downregulation of n
Broad Institute
NOVEMBER 18, 2024
Cancer Immunotherapy Data Science Challenge - Lecture 3, Part B - Data - Data Overview By Rose Circeo November 18, 2024 Breadcrumb Home Cancer Immunotherapy Data Science Challenge - Lecture 3, Part B - Data - Data Overview The "Cancer Immunotherapy Data Science Challenge: Reprogramming T Cells to Combat Tumors" was born of the desire to leverage rapid advances in single-cell sequencing technologies and the power of machine learning to improve cancer treatment.
ACTO
NOVEMBER 18, 2024
Helping Mutual Customers Elevate the “Human Touch” Element of Their Omnichannel Engagement Strategies MADRID, Spain – Veeva Commercial Summit – November 19, 2024 – ACTO today announced it expanded its product partnership with Veeva by joining the Veeva AI Partner Program to help advance the use of Generative AI (GenAI) in life sciences. ACTO offers GenAI products that help field-based representatives with messaging during face-to-face interactions with healthcare providers (HCPs).
Broad Institute
NOVEMBER 18, 2024
Cancer Immunotherapy Data Science Challenge - Lecture 3, Part A - Data - Experiment Overview By Rose Circeo November 18, 2024 Breadcrumb Home Cancer Immunotherapy Data Science Challenge - Lecture 3, Part A - Data - Experiment Overview The "Cancer Immunotherapy Data Science Challenge: Reprogramming T Cells to Combat Tumors" was born of the desire to leverage rapid advances in single-cell sequencing technologies and the power of machine learning to improve cancer treatment.
Crucial Data Solutions
NOVEMBER 18, 2024
Let’s be real: managing clinical trials is tough enough without juggling multiple disconnected systems. Yet for many research teams, that’s. The post Maximizing Site Performance: The Hidden Benefits of Unified eConsent and EDC appeared first on Crucial Data Solutions.
Broad Institute
NOVEMBER 18, 2024
Cancer Immunotherapy Data Science Challenge - Lecture 2, Part C - Tech - Measuring Perturbations in Cells By Rose Circeo November 18, 2024 Breadcrumb Home Cancer Immunotherapy Data Science Challenge - Lecture 2, Part C - Tech - Measuring Perturbations in Cells The "Cancer Immunotherapy Data Science Challenge: Reprogramming T Cells to Combat Tumors" was born of the desire to leverage rapid advances in single-cell sequencing technologies and the power of machine learning to improve cancer treatmen
Expert insights. Personalized for you.
128 
Let's personalize your content